We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

A Merck & Co. effort to move its PD-1 behemoth Keytruda into early treatment of lung cancer has reached a dead end, along with another bid to expand into a type of early-stage skin cancer.

A 67-year-old London man with lung cancer has been the first to receive a new cancer vaccine as part of an international trial. The early-stage research will test the immune therapy’s safety and ...

The mRNA revolution continues. Just a few years after mRNA vaccines proved their efficacy against COVID-19, scientists are now turning their attention to lung cancer. The mRNA vaccine, known as ...

Ipswich: Muric, Tuanzebe, Woolfenden, Greaves, Davis, Morsy, Luongo, Johnson, Szmodics, Hutchinson, Delap Defending champion Manchester City takes on newly promoted Ipswich Town as it eyes consecutive ...

As your White House correspondent, I ask the tough questions and seek the answers that matter. Your support enables me to be in the room, pressing for transparency ...

A patient in the UK is among the first Europeans to participate in a groundbreaking global trial for a lung cancer vaccine. Lung cancer is the leading cause of cancer death worldwide, responsible ...

The world’s first lung cancer vaccination trials have begun in the United Kingdom. Janusz Racz, a 67-year-old lung cancer patient, is the first to receive this groundbreaking vaccine. He is part ...

A 67-year-old man has become the first person in the UK to try what doctors hope will be a revolutionary new treatment for lung cancer - a vaccine that tells the body how to fight and kill the ...